Clinical Trial Update: Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports the safety and efficacy of the Buprenorphine Transdermal System (BTDS) in adults with chronic noncancer pain. The results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noncancer Pain

Drugs mentioned

• Buprenorphine Transdermal System (BTDS) (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Chronic Non-malignant Pain | Phase 3 | Status: COMPLETED | Results posted: 2010-10-15